Dr Muithi Mwangangi Mwanthi, MD in Saint Louis, MO - Medicare Dermatology

Dr Muithi Mwangangi Mwanthi, MD is a medicare enrolled "Dermatology" physician in Saint Louis, Missouri. He went to Indiana University School Of Medicine and graduated in 2014 and has 10 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Washington University and his current practice location is 4901 Forest Park Ave, Div Im Dermatology, Ste 502, Saint Louis, Missouri. You can reach out to his office (for appointments etc.) via phone at (314) 273-3376.

Dr Muithi Mwangangi Mwanthi is licensed to practice in Missouri (license number 2018017778) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1568872901.

Contact Information

	Dr Muithi Mwangangi Mwanthi, MD
	4901 Forest Park Ave, Div Im Dermatology, Ste 502, Saint Louis, MO 63108-1495
	(314) 273-3376
	(888) 665-8309

Physician's Profile

Full Name	Dr Muithi Mwangangi Mwanthi
Gender	Male
Speciality	Dermatology
Experience	10 Years
Location	4901 Forest Park Ave, Saint Louis, Missouri
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Muithi Mwangangi Mwanthi attended and graduated from Indiana University School Of Medicine in 2014

NPI Data:

NPI Number: 1568872901
Provider Enumeration Date: 05/07/2014
Last Update Date: 04/25/2024

Medicare PECOS Information:

PECOS PAC ID: 5890910897
Enrollment ID: I20181004000674

Medical Identifiers

Medical identifiers for Dr Muithi Mwangangi Mwanthi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568872901	NPI	-	NPPES
200060392	Medicaid	MO

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	2018017778 (Missouri)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Barnes Jewish Hospital	Saint louis, MO	Hospital
Christian Hospital Northeast	Saint louis, MO	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Washington University	9830008770	2506

News Archive

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would earn 30 percent patient share according to surveyed U.S. cardiologists

SLU researcher reports success in identifying new drug targets for muscular dystrophy

In a recent paper published in the journal Skeletal Muscle, a Saint Louis University researcher reports success in identifying new drug targets that potentially could slow or halt the progression of a form muscular dystrophy, an illness characterized by progressive muscle degeneration.

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Now that the badly botched rollout of the federal government's health care website seems to be behind us, Republicans have shifted their criticisms to several states that are experiencing problems enrolling people on their state-run exchanges.

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Emisphere Technologies, Inc. today announced that an independent Data Monitoring Committee ("DMC") informed Novartis and its partner Nordic Bioscience about their recommendation to proceed with the Osteoporosis ("OP") Phase 3 Study 2303 and the Osteoarthritis ("OA") Phase 3 Study 2301 exploring the safety and efficacy of an oral formulation of salmon calcitonin to treat patients with osteoporosis and osteoarthritis of the knee.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Muithi Mwangangi Mwanthi allows following entities to bill medicare on his behalf.

Entity Name	Washington University
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372

News Archive

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

SLU researcher reports success in identifying new drug targets for muscular dystrophy

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Muithi Mwangangi Mwanthi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Muithi Mwangangi Mwanthi, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 273-3376	Dr Muithi Mwangangi Mwanthi, MD 4901 Forest Park Ave, Div Im Dermatology, Ste 502, Saint Louis, MO 63108-1495 Ph: (314) 273-3376

News Archive

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

SLU researcher reports success in identifying new drug targets for muscular dystrophy

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Dermatology Doctors in Saint Louis, MO

Dr. Caroline M Mann, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 969 N Mason Rd, Div Im Dermatology, Ste 220, Saint Louis, MO 63141 Phone: 314-273-3376 Fax: 888-682-0525
Dr. Eva A. Hurst, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 969 N Mason Rd Ste 200, Ste 200, Saint Louis, MO 63141 Phone: 314-996-8810 Fax: 314-996-8775
Shane A Grace, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12855 N 40 Dr Ste 180, Saint Louis, MO 63141 Phone: 314-878-5599 Fax: 314-392-4290
Dr. Lee S Portnoff, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3009 N Ballas Rd, Ste 310a, Saint Louis, MO 63131 Phone: 314-993-2909
Aibing Mary Guo, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1225 S Grand Blvd Fl 3, Saint Louis, MO 63104 Phone: 314-977-3400 Fax: 314-977-7613
Dr. Amy C Musiek, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4901 Forest Park Ave, Div Im Dermatology, Ste 502, Saint Louis, MO 63108 Phone: 314-273-3376 Fax: 888-665-8309
Dr. Gillian Meade Heinecke, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1755 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-256-3430 Fax: 314-256-3431

Dr Muithi Mwangangi Mwanthi, MD - Medicare Dermatology in Saint Louis, MO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

SLU researcher reports success in identifying new drug targets for muscular dystrophy

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Study could provide novel treatment strategy for potentially blinding problem

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Medicare Reassignments

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

SLU researcher reports success in identifying new drug targets for muscular dystrophy

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Study could provide novel treatment strategy for potentially blinding problem

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

SLU researcher reports success in identifying new drug targets for muscular dystrophy

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Study could provide novel treatment strategy for potentially blinding problem

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Dermatology Doctors in Saint Louis, MO